Amarantus Bioscience Holdings, Inc. Commercialization On-Track for 2014: Updating LymPro Test(R) Progress - kcentv.com - KCEN HD - Waco, Temple, and Killeen

Amarantus Bioscience Holdings, Inc. Commercialization On-Track for 2014: Updating LymPro Test(R) Progress

Posted: Updated:

SAN FRANCISCO, CA / March 31, 2014 / Amarantus Bioscience Holdings, Inc. (OTCQB: AMBS) today published a new blog post on The Chairman’s Blog, written by the Company’s CEO, Mr. Gerald Commissiong. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In his blog, Mr. Commissiong outlines Amarantus’ recent achievement of key milestones that the company believes will add significant value in the commercialization and development of the LymPro test (R) for Alzheimer’s. “As we prepare for LymPro’s commercialization in the second half of 2014, we believe it is critical to properly position LymPro within the scientific community, the investment community and the general population as THE commercially-validated blood test as we prepare for product launch,” states Mr. Commissiong. Read the full blog post from Mr. Gerald Commissiong on TheChairmansBlog.com (http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/commercialization-track-2014-updating-lympro-test-progress/).

About Amarantus

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The Company has licensed Eltoprazine (“Eltoprazine”), a phase 2b ready indication for Parkinson’s Levodopa induced dyskinesia and Adult ADHD. The Company has an exclusive worldwide license to the Lymphocyte Proliferation test (“LymPro Test®”) for Alzheimer’s disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (“MANF”) and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property for the diagnosis of Parkinson’s disease (“NuroPro”) and the discovery of neurotrophic factors (“PhenoGuard”). For further information please visit www.Amarantus.com, or connect with the Company on Facebook, LinkedIn, Twitter and Google+.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

 

SOURCE: Amarantus Bioscience Holdings, Inc.

ReleaseID: 413716

  • Latest NewsMore>>

  • Ground Broken for Ft. Hood Shooting Memorial

    Ground Broken for Ft. Hood Shooting Memorial

    Tuesday, July 22 2014 1:35 PM EDT2014-07-22 17:35:22 GMT
    Photo Courtesy Sophia Stamas, KCEN NewsPhoto Courtesy Sophia Stamas, KCEN News
    The ground has been broken for a memorial to the victims of the Nov 5, 2009 shooting on Fort Hood. 13 people were killed, one of them with child, making 14.32 others were wounded Stillll more money is needed to complete the project just outside of the Killeen Civic Center, which will stand as a reminder of their sacrifice.The widow of the sole civilian killed spoke at the ceremony before joining city leaders and those who are working to make the memorial possible.13 sculptures include ...More >>
    The ground has been broken for a memorial to the victims of the Nov 5, 2009 shooting on Fort Hood. 13 people were killed, one of them with child, making 14.32 others were wounded Stillll more money is needed to complete the project just outside of the Killeen Civic Center, which will stand as a reminder of their sacrifice.The widow of the sole civilian killed spoke at the ceremony before joining city leaders and those who are working to make the memorial possible.13 sculptures include ...More >>
  • UPDATES: U.S. Airlines Suspend Israel Flights, Citing Security Concerns

    UPDATES: U.S. Airlines Suspend Israel Flights, Citing Security Concerns

    Tuesday, July 22 2014 12:21 PM EDT2014-07-22 16:21:22 GMT
    Delta Air Lines on Tuesday suspended flights to Israel's main international airport because of reports about a nearby rocket attack, the company said.Citing "reports of a rocket or associated debris" near Ben Gurion Airport near Tel Aviv, Delta said it suspended service between its hub in New York and Tel Aviv "to ensure the safety and security of our customers and employees."One immediate effect: Flight 468, which left New York's John F. Kennedy International Airport with 273 passen...More >>
    Delta Air Lines on Tuesday suspended flights to Israel's main international airport because of reports about a nearby rocket attack, the company said.Citing "reports of a rocket or associated debris" near Ben Gurion Airport near Tel Aviv, Delta said it suspended service between its hub in New York and Tel Aviv "to ensure the safety and security of our customers and employees."One immediate effect: Flight 468, which left New York's John F. Kennedy International Airport with 273 passen...More >>
  • Court Strikes Down Federal Obamacare Subsidies

    Court Strikes Down Federal Obamacare Subsidies

    Tuesday, July 22 2014 11:11 AM EDT2014-07-22 15:11:14 GMT
    In a potentially lethal blow to Obamacare, a federal appeals court has ruled that the federal government may not subsidize health insurance plans bought by people in states that decided not to set up their own marketplaces under Obamacare.The law clearly says that states are to set up the exchanges. But 34 states opted not to, and the federal government took over in those states. The court ruled that federal government may not pay subsidies for insurance plans in those states."W...More >>
    In a potentially lethal blow to Obamacare, a federal appeals court has ruled that the federal government may not subsidize health insurance plans bought by people in states that decided not to set up their own marketplaces under Obamacare.The law clearly says that states are to set up the exchanges. But 34 states opted not to, and the federal government took over in those states. The court ruled that federal government may not pay subsidies for insurance plans in those states."W...More >>
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KCEN. All Rights Reserved. Users of this site agree to the Terms of Service, Privacy Notice/Your California Privacy Rights, and Ad Choices.